AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...
Ultibro Breezhaler (indacaterol / glycopyrronium bromide) and Seebri Breezhaler (glycopyrronium bromide) in the United Kingdom will both be marketed by Pfizer, an arrangement that will be unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback